Literature DB >> 20521328

E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation.

Taotao Chen1, Detian Yuan, Bin Wei, Jing Jiang, Jiuhong Kang, Kun Ling, Yijun Gu, Jinsong Li, Lei Xiao, Gang Pei.   

Abstract

The low efficiency of reprogramming and genomic integration of virus vectors obscure the potential application of induced pluripotent stem (iPS) cells; therefore, identification of chemicals and cooperative factors that may improve the generation of iPS cells will be of great value. Moreover, the cellular mechanisms that limit the reprogramming efficiency need to be investigated. Through screening a chemical library, we found that two chemicals reported to upregulate E-cadherin considerably increase the reprogramming efficiency. Further study of the process indicated that E-cadherin is upregulated during reprogramming and the established iPS cells possess E-cadherin-mediated cell-cell contact, morphologically indistinguishable from embryonic stem (ES) cells. Our experiments also demonstrate that overexpression of E-cadherin significantly enhances reprogramming efficiency, whereas knockdown of endogenous E-cadherin reduces the efficiency. Consistently, abrogation of cell-cell contact by the inhibitory peptide or the neutralizing antibody against the extracellular domain of E-cadherin compromises iPS cell generation. Further mechanistic study reveals that adhesive binding activity of E-cadherin is required. Our results highlight the critical role of E-cadherin-mediated cell-cell contact in reprogramming and suggest new routes for more efficient iPS cell generation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521328     DOI: 10.1002/stem.456

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  108 in total

1.  E-cadherin regulates the behavior and fate of epithelial stem cells and their progeny in the mouse incisor.

Authors:  Chun-Ying Li; Wanghee Cha; Hans-Ulrich Luder; Roch-Philippe Charles; Martin McMahon; Thimios A Mitsiadis; Ophir D Klein
Journal:  Dev Biol       Date:  2012-04-18       Impact factor: 3.582

2.  Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway.

Authors:  Mengfei Chen; He Zhang; Jie Wu; Liang Xu; Di Xu; Jingnan Sun; Yixin He; Xin Zhou; Zhaojing Wang; Lifang Wu; Shaokun Xu; Jinsong Wang; Shu Jiang; Xiangjun Zhou; Andrew R Hoffman; Xiang Hu; Jifan Hu; Tao Li
Journal:  Biomaterials       Date:  2012-05-09       Impact factor: 12.479

Review 3.  Roles of small molecules in somatic cell reprogramming.

Authors:  Jian-bin Su; Duan-qing Pei; Bao-ming Qin
Journal:  Acta Pharmacol Sin       Date:  2013-06-03       Impact factor: 6.150

Review 4.  Chemical approaches to stem cell biology and therapeutics.

Authors:  Wenlin Li; Ke Li; Wanguo Wei; Sheng Ding
Journal:  Cell Stem Cell       Date:  2013-09-05       Impact factor: 24.633

5.  Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.

Authors:  Mong-Jen Chen; Yuanqing Lu; Takashi Hamazaki; Hsin-Yin Tsai; Kirsten Erger; Thomas Conlon; Ahmed S Elshikha; Hong Li; Arun Srivastava; Chunli Yao; Mark Brantly; Vince Chiodo; William Hauswirth; Naohiro Terada; Sihong Song
Journal:  Hum Gene Ther Methods       Date:  2013-12-28       Impact factor: 2.396

Review 6.  Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.

Authors:  Bhavita Walia; Neeraj Satija; Rajendra Prashad Tripathi; Gurudutta U Gangenahalli
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 7.  Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.

Authors:  Daekee Kwon; Minjun Ji; Seunghee Lee; Kwang Won Seo; Kyung-Sun Kang
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

8.  Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Authors:  Begoña Martin-Castillo; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Silvia Cufí; José Manuel Moreno; Bruna Corominas-Faja; Ander Urruticoechea; Ángel G Martín; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

9.  Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines.

Authors:  Lois A Annab; Carl D Bortner; Marie I Sifre; Jennifer M Collins; Ruchir R Shah; Darlene Dixon; H Karimi Kinyamu; Trevor K Archer
Journal:  Differentiation       Date:  2012-08-18       Impact factor: 3.880

Review 10.  Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics.

Authors:  Melissa A Kinney; Tracy A Hookway; Yun Wang; Todd C McDevitt
Journal:  Ann Biomed Eng       Date:  2013-12-03       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.